ES2136062T3 - Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ... - Google Patents

Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ...

Info

Publication number
ES2136062T3
ES2136062T3 ES91106110T ES91106110T ES2136062T3 ES 2136062 T3 ES2136062 T3 ES 2136062T3 ES 91106110 T ES91106110 T ES 91106110T ES 91106110 T ES91106110 T ES 91106110T ES 2136062 T3 ES2136062 T3 ES 2136062T3
Authority
ES
Spain
Prior art keywords
recombinant
proteins
genes
plasmid
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91106110T
Other languages
English (en)
Inventor
Giulio Ratti
Maurizio Comanducci
Mario F Tecce
Marzia M Giuliani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sclavo SpA
Original Assignee
Sclavo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo SpA filed Critical Sclavo SpA
Application granted granted Critical
Publication of ES2136062T3 publication Critical patent/ES2136062T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE DESCRIBE UN PLASMIDO AISLADO DE LA CLAMYDIA TRACHOMATIS QUE CONSTA DE 8 GENES QUE CODIFICAN PROTEINAS UTILES EN LA FORMULACION DE VACUNAS O ANALISIS DIAGNOSTICOS PARA DETERMINAR LA BACTERIA O ANTICUERPOS ESPECIFICOS GENERADOS DURANTE LAS INFECCIONES DE C. TRACHOMATIS; SE DESCRIBE PARTICULARMENTE LA FUSION RECOMBINANTE DE LA PROTEINA MS2-PGP3D QUE CONSTA DE LAS SECUENCIAS POLIPEPTIDICAS CODIFICADAS POR PCT E INMUNOGENICA EN EL CURSO DE LAS INFECCIONES EN EL HOMBRE. TAMBIEN SE DESCRIBE UN METODO PARA PREPARAR PROTEINA MENCIONADA EN E.COLI.
ES91106110T 1991-02-07 1991-04-17 Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ... Expired - Lifetime ES2136062T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910314A IT1244706B (it) 1991-02-07 1991-02-07 Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici

Publications (1)

Publication Number Publication Date
ES2136062T3 true ES2136062T3 (es) 1999-11-16

Family

ID=11358472

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91106110T Expired - Lifetime ES2136062T3 (es) 1991-02-07 1991-04-17 Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ...

Country Status (8)

Country Link
US (2) US6110705A (es)
EP (1) EP0499681B1 (es)
AT (1) ATE181104T1 (es)
DE (1) DE69131319T2 (es)
DK (1) DK0499681T3 (es)
ES (1) ES2136062T3 (es)
GR (1) GR3030447T3 (es)
IT (1) IT1244706B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629167A (en) * 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US5814490A (en) * 1996-06-11 1998-09-29 Becton, Dickinson And Company Amplification and detection of chlamydia trachomatis nucleic acids
IL119938A (en) * 1996-12-30 2005-08-31 Yissum Res Dev Co Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
GB0016814D0 (en) 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (3)
NZ562929A (en) 2001-12-12 2009-07-31 Novartis Vaccines & Diagnostic Immunisation against chlamydia trachomatis
JP2010526070A (ja) * 2007-05-01 2010-07-29 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム Ｃｈｌａｍｙｄｉａ感染及び疾患の診断ならびに治療のための薬剤としてのＣｈｌａｍｙｄｉａ抗原
CA2739111A1 (en) 2008-10-09 2010-04-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650571T2 (de) * 1985-01-14 1997-02-27 Chiron Corp Hauptprotein der Aussenmembran von Chlamydia
GB8709746D0 (en) * 1987-04-24 1987-05-28 Wenman W M Chlamydia vaccine
IT1224253B (it) * 1988-04-08 1990-09-26 Sclavo Spa Oligonucleotidi sintetici utili per la determinazione di chlamydia trachomatis in un campione biologico

Also Published As

Publication number Publication date
EP0499681A1 (en) 1992-08-26
DE69131319T2 (de) 1999-12-16
US6096519A (en) 2000-08-01
US6110705A (en) 2000-08-29
ATE181104T1 (de) 1999-06-15
DK0499681T3 (da) 1999-11-15
EP0499681B1 (en) 1999-06-09
DE69131319D1 (de) 1999-07-15
ITMI910314A1 (it) 1992-08-07
ITMI910314A0 (it) 1991-02-07
IT1244706B (it) 1994-08-08
GR3030447T3 (en) 1999-09-30

Similar Documents

Publication Publication Date Title
MX6339E (es) Metodo para elaborar dentro de un huesped bacteriano y excretar a traves de la membrana de la celula huesped,una proteina o un polipeptido seleccionados
DK0574466T3 (da) Udtrykkelse af rekombinante proteiner i svækkede bakterier
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
ES2194010T3 (es) Mejoras en el diagnostico y profilaxis de la borrelia burgdorferi.
ATE363535T1 (de) Stabile bakterizide proteine, welche die permeabilität erhöhen und pharmazeutische zusammensetzungen, diese enthaltend
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ES2093122T3 (es) Activacion mejorada de proteinas recombinantes.
ES2136062T3 (es) Plasmido pctd aislado de chlamydia trachomatis serotipo d, genes y proteinas codificados por el mismo; plasmidos recombinantes para la expresion de dichos genes en sistemas heterologos como proteinas recombinantes de fusion, preparacion de dichas proteinas recombinantes y ...
DE69634510T2 (de) Mutantes SPE-A-Toxin und dessen Verwendung
ATE287963T1 (de) Pseudomonas exotoxin - myelin basisches protein chimäre proteine
CU22222A1 (es) Procedimiento para la expresion de proteinas heterologicas producidas de forma fusionada en escherichia coli, su uso, vectores de expresion y cepas recombinantes
AR027484A1 (es) Proteina de fusion util en el tratamiento o prevencion del herpes zoster y en la prevencion o tratamiento de infecciones de varicela, adn y arn quecodifican dicha proteina; vectores de expresion y microorganismos recombinantes que comprenden dicho adn o arn; composiciones de vacuna que incluyen dich
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
ATE435915T1 (de) Spezifische nukleinsäuren und polypeptide aus krankheitserregenden stämmen von neisseria
NO923828L (no) Polypeptider, nyttige til diagnose av og behandling mot mycoplasma-infeksjoner hos dyr
AR020945A1 (es) Polinucleotidos optimizados para la expresion en plantas que codifican proteinas pesticidas del tipo 43f y 80jj1/130
PT93381A (pt) Processo para a preparacao de proteina placentaria 9(pp9), de anticorpos contra esta proteina, de composicoes farmaceuticas que a contem e de agentes de diagnostico que contem uma sequencia de adn que codifica para a respectiva sequencia de acidos aminados

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 499681

Country of ref document: ES